Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
11
×
biotech
boston blog main
life sciences
national blog main
national top stories
biotech & health
boston top stories
cancer
clinical trials
deals
new york blog main
boston
detroit blog main
detroit top stories
funding
healthtech
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
tech
texas blog main
texas top stories
venture
venture capital
wisconsin blog main
wisconsin top stories
abbvie
accelerator
adeno-associated virus
africa
airbnb
akouos
What
years
11
×
medicines
startup
ago
founder
medical
new
sciences
accidentally
adds
admits
ceo
coming
drug
experience
health
help
join
life
medicine
stage
takes
techcrunch
therapeutics
access
according
acquisitions
adding
address
adherence
african
africa’s
agenda
aiming
allosteric
animals
announced
announcing
answers
approach
Language
unset
11
×
Current search:
unset
×
startups
×
years
×
@techcrunch.com
4 months ago
My Memo adds some pill-zazz to automatic medicine dispensers
@techcrunch.com
9 months ago
Lindus Health, a U.K. clinical trials startup backed by Peter Thiel, raises $18M
@techcrunch.com
9 months ago
Announcing the AI Stage agenda at TechCrunch Disrupt 2023
@techcrunch.com
1 year ago
Singapore’s Ora takes a vertically-integrated approach to telehealth
@techcrunch.com
1 year ago
South Africa’s Envisionit Deep AI gets $1.65M to expand access to medical imaging
@techcrunch.com
2 years ago
Injectsense collects $1.7M grant for its eye implant smaller than a grain of rice
@geekwire.com
3 years ago
Investment arms of Jeff Bezos and Paul Allen join $76M round for secretive biotech startup led by Isilon co-founder, Stanford professor
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In